BlackRock Inc. - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$128,643,000
+96.1%
3,734,188
-4.9%
0.01%
+66.7%
Q2 2020$65,607,000
+25.3%
3,926,120
+8.2%
0.00%0.0%
Q1 2020$52,342,000
-57.5%
3,629,954
-1.3%
0.00%
-40.0%
Q4 2019$123,066,000
+62.2%
3,676,895
+1.5%
0.01%
+66.7%
Q3 2019$75,856,000
+2.8%
3,622,557
+2.2%
0.00%0.0%
Q2 2019$73,767,000
-11.0%
3,543,155
-4.5%
0.00%
-25.0%
Q1 2019$82,926,000
-6.9%
3,710,376
-0.3%
0.00%0.0%
Q4 2018$89,056,000
-18.0%
3,723,111
-6.5%
0.00%
-20.0%
Q3 2018$108,644,000
+10.9%
3,982,580
+9.3%
0.01%0.0%
Q2 2018$97,984,0000.0%3,643,840
+18.4%
0.01%0.0%
Q1 2018$97,984,000
-5.6%
3,078,430
+12.2%
0.01%0.0%
Q4 2017$103,771,000
+51.0%
2,743,812
-1.0%
0.01%
+66.7%
Q3 2017$68,716,000
+27.9%
2,772,008
+6.1%
0.00%0.0%
Q2 2017$53,735,000
+15.5%
2,613,608
+22.0%
0.00%0.0%
Q1 2017$46,543,000
+89405.8%
2,141,889
+84426.0%
0.00%
Q4 2016$52,000
+30.0%
2,534
-4.3%
0.00%
Q3 2016$40,000
+300.0%
2,649
+177.7%
0.00%
Q2 2016$10,000
+66.7%
954
+107.4%
0.00%
Q1 2016$6,0004600.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders